top of page
TheCellStation
News,
Events &
Insights

All Posts


Industry Insight: The Hidden Cost of Variable Cardiomyocytes - A $2.6 Billion Problem
Published on Celogics Inc. Blog - The Cell Station | September 18, 2025 In pharmaceutical boardrooms around the world, executives grapple...
Sep 18


The Art and Science of Making "Good" Cardiomyocytes: Why Heart Cells Are the Ultimate Cell Engineering Challenge
Published on Celogics Inc. Blog - The Cell Station | Aug 27, 2025 "What makes a good cardiomyocyte?" It's a question that sounds...
Aug 27


iPSC-Therapies: How 18 Years of Development Reached the Commercial Inflection Point
Published on Celogics.com | Aug 21, 2025 Eighteen years after Shinya Yamanaka's groundbreaking discovery of induced pluripotent stem...
Aug 21


The Genomics Revolution: How Economies of Scale Are Making Personalized Medicine Accessible to All
Published on www.Celogics.com TheCellStation | Aug 13, 2025 The healthcare industry stands at an inflection point. What began as a...
Aug 13


Recent FDA Approvals & Designations Signal New Era for Cell Therapy Innovation
Published on celogics.com | Aug 12, 2025 The biotechnology landscape is experiencing a remarkable transformation, and the latest FDA...
Aug 11


2023 SPS Annual Meeting
Celogics is attending the Safety Pharmacology Society (SPS) Annual Meeting 2023 held in Belgium! Our CEO, Jin Chang will be speaking in...
Sep 4, 2023
bottom of page